7 Key Insights: Driving toward better patient outcomes in drug development

How clinical teams are leveraging digital biomarkers in clinical trials to measure what matters and improve quality of life for patients.

5 Years and 100 Hats: Building HumanFirst from Idea to Acquisition

Big News — ICON Acquires HumanFirst to Deliver Enhanced Precision Measurement Solutions in Clinical Research

The Rise of Precision Measures

Precision measures are the means by which to evaluate a meaningful change on the exact outcome of interest, regardless of tool or instrument.

Year in Review: Driving precision health strategies forward

Tested, Tried and True: Why digital biomarkers are the AI & ML strategy pharma should prioritize

Rather than chasing generative AI, pharma executives can focus their AI & ML strategies for drug development on investing in and deploying connected sensors to reduce costs & improve patient outcomes.

Utilizing connected sensors to power diverse and equitable clinical trials

Our newest publication in Nature npj Digital Medicine outlines current evidence and a solution framework for diversity in research using digital health technologies

Make Better Decisions with Evidence-based Comparisons in Atlas

Compare instruments in Atlas based on measure categories and evidence coverage to make informed decisions

Digital endpoints widely adopted in pharmaceutical and biotech-sponsored clinical trials

Over 130 pharma and biotech organizations have relied on AI-powered digital biomarkers and sensor-derived clinical outcome assessments (COAs) to capture patient-centered endpoints

Make Accurate Decisions Faster with Atlas Projects

Surface answers quickly and track progress easily with new capabilities in the Atlas Platform

HumanFirst enables a new way to select fit-for-purpose COAs to simplify clinical protocols

HumanFirst Launches New Enterprise Platform to Accelerate Adoption of Precision Measures and Artificial Intelligence in Clinical Research

HumanFirst’s new solution aligns AI-powered biomarkers and clinical outcome assessments (COAs) across one platform to drive scientific progress, R&D efficiencies, and patient-centered research

Accelerate the adoption of evidence-based digital biomarkers in your study protocol

How HumanFirst’s new Atlas Workspaces makes it easier for life sciences R&D and commercial teams to evaluate digital measures during the study protocol design process

What it’s like to be a product engineer at HumanFirst

Today, we’re catching up with product engineers Giselle Rogers and James Ward to learn more about what it’s like to work at HumanFirst, an organization on a mission to enable the seamless incorporation of digital health technologies & digital biomarkers into clinical research, resulting in better, differentiated treatments that improve health outcomes for all humans.

Introducing the HumanFirst API

Building better applications for precision measures, digital health technologies and digital biomarkers

Finding Precision Measures that Matter

The final entry in a three-part series about the digital measurement landscape.

Composability: The key to safe and effective digital biomarkers

As you design your digital measures, how will you select your tech stack? Select the right digital health technologies and digital biomarkers with HumanFirst and measure what matters.

More than 600 companies are developing digital biomarkers — how do you choose the right one?

HumanFirst is dropping the first of three infographics mapping the landscape of companies developing evidence-based digital health technologies (DHTs) across 13+ therapeutic areas

Introducing AtlasEDU by HumanFirst

The industry’s most comprehensive platform for digital health technologies and digital biomarkers is now available free of charge to qualified academic researchers.

Driving Towards Measures that Matter

Why HumanFirst is launching 25 measure ontologies covering 11k+ digital measures across 800+ medical conditions